Company profile
Latigo Biotherapeutics, Inc.
Uniquely poised to disrupt pain therapy.
- Industry
- Biotechnology Research
- Employees
- 61
- Headquarters
- Thousand Oaks, CA
- LinkedIn followers
- 9,286
- Office locations
- 1
Latigo Biotherapeutics, Inc. company summary
Latigo Biotherapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Thousand Oaks, CA. On LinkedIn the company has around 61 employees and 9,286 followers.
What technology does Latigo Biotherapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics is a private clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction, with the goal to provide effective, rapid-acting pain relief. Latigo is supported by leading investors, including Westlake Village BioPartners, Foresite Capital, 5AM Ventures, and Blue Owl Capital. Latigo’s lead program is LTG-001, an oral, selective Nav1.8 inhibitor in development to treat acute pain.
Where is Latigo Biotherapeutics, Inc. located?
Latigo Biotherapeutics, Inc. lists 1 location.
Compare companies similar to Latigo Biotherapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Latigo Biotherapeutics, Inc. latigobio.com | Biotechnology Research | 61 | - | Thousand Oaks, CA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Latigo Biotherapeutics, Inc.
What does Latigo Biotherapeutics, Inc. do?
Latigo Biotherapeutics is a private clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction, with the goal to provide effective, rapid-acting pain relief. Latigo is supported by leading investors, including Westlake Village BioPartners, Foresite Capital, 5AM Ventures, and Blue Owl Capital. Latigo’s lead program is LTG-001, an oral, selective Nav1.8 inhibitor in development to treat acute pain.
How many employees does Latigo Biotherapeutics, Inc. have?
Latigo Biotherapeutics, Inc. has around 61 employees on LinkedIn.
Where is Latigo Biotherapeutics, Inc. headquartered?
Latigo Biotherapeutics, Inc. is headquartered in Thousand Oaks, CA.
Build a lead list from companies like Latigo Biotherapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.